rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    ELUT
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Elutia Inc. Q3 2026 Earnings Call Summary
      Nov 6Yahoo FinanceELUT
      Elutia Inc (ELUT) Q3 2026 Earnings Call Highlights: Cardiovascular Growth and NXT-41X Momentum ...
      Nov 6Yahoo FinanceELUT
      Elutia Q3 2026 Earnings Call Transcript
      Nov 5BenzingaELUT
      Elutia earnings beat by $0.09, revenue fell short of estimates
      Nov 5Investing.comELUT
      Elutia Reports Third Quarter 2026 Results: As Plastic Surgeons Cite Infection Risk in Every Breast Research Session During National Meeting, NXT-41x Heads to FDA This Quarter, Fully Funded Through Launch
      Nov 5Yahoo FinanceELUT
      Earnings To Watch: Elutia Inc (ELUT) Q3 2026 -- GF Value Sees 57% Downside
      Nov 4Yahoo FinanceELUT
      Elutia to Report Third Quarter 2026 Financial Results on Thursday, November 5, 2026
      Oct 22Yahoo FinanceELUT
      Elutia receives $8 million escrow from Boston Scientific sale
      Oct 1Investing.comELUT
      Elutia Reports $8 Million Payment from Boston Scientific
      Oct 1Yahoo FinanceELUT
      12 Health Care Stocks Moving In Thursday's After-Market Session - Elutia (NASDAQ:ELUT), Intelligent Bio S

      Gainers Elutia (NASDAQ:ELUT) stock moved upwards by 17.2% to $0.94 during Thursday's after-market session. The market value of their outstanding shares is at $34.9 million. Intelligent Bio Solutions (NASDAQ:INBS)

      Oct 1BenzingaELUTINBSSBFMSBFMW
      Elutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029
      Oct 1Yahoo FinanceELUT
      Elutia at H.C. Wainwright conference: capital, data and launch path
      Sep 11Investing.comELUT
      Elutia to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 15th
      Sep 10Yahoo FinanceELUT
      Elutia to Participate in the Lake Street Capital Markets 10th Annual Big Ideas Growth Conference & the H.C. Wainwright 28th Annual Global Investment Conference

      GAITHERSBURG, Md., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) ("Elutia" or the "Company"), a pioneer in drug-eluting biomatrix technologies, today announced that Dr. Randy Mills, Chief Executive Officer, Matthew Ferguson, Chief Financial Officer, and Dr. Michelle Williams, Chief Scientific Officer, will participate in two upcoming investor conferences. Lake Street Capital Markets 10th Annual Big Ideas Growth ConferenceElutia will host one-on-one meetings with investors at the

      Sep 2Yahoo FinanceELUT

      This is the newest page. Registered accounts read further back.